Clinical Trial Update: A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone

View source ↗

Summary

Clinical trial update for ixazomib plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• And or Refractory Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• ixazomib (ixazomib)

Snippet

Sponsor: Takeda | Conditions: Relapsed and/or Refractory Multiple Myeloma | Status: COMPLETED | Results posted: 2023-12-07